Read on Twitter
India manufactures more vaccines than any other country. So why is it running short of Covid-19 vaccines?
There& #39;s no one answer. Instead, I reconstructed the last 12 months and built a timeline of dysfunction. The dysfunction was born of... [1] https://qz.com/2004650/?utm_term=mucp">https://qz.com/2004650/...
There& #39;s no one answer. Instead, I reconstructed the last 12 months and built a timeline of dysfunction. The dysfunction was born of... [1] https://qz.com/2004650/?utm_term=mucp">https://qz.com/2004650/...
...decisions made (or not made) in Delhi, Pune, Seattle, Washington and Oxford.
It was born out of corporate profiteering. And out of totally opaque deal-making in the midst of a pandemic, even as the research and manufacturing were being primed by public money: [2]
![...decisions made (or not made) in Delhi, Pune, Seattle, Washington and Oxford. It was born out of corporate profiteering. And out of totally opaque deal-making in the midst of a pandemic, even as the research and manufacturing were being primed by public money: [2]](https://pbs.twimg.com/media/E0ro5QmWYAoHHZq.png "...decisions made (or not made) in Delhi, Pune, Seattle, Washington and Oxford. It was born out of corporate profiteering. And out of totally opaque deal-making in the midst of a pandemic, even as the research and manufacturing were being primed by public money: [2]")
It was born out of corporate profiteering. And out of totally opaque deal-making in the midst of a pandemic, even as the research and manufacturing were being primed by public money: [2]
It was born out of how the global pharma industry is stacked in favour of big corporations.
The Oxford vaccine& #39;s inventors, at first, wanted to make their vaccine non-exclusive—a potential boon for India, which has dozens of vaccine plants. But then the plan changed: [3]
![It was born out of how the global pharma industry is stacked in favour of big corporations. The Oxford vaccine& #39;s inventors, at first, wanted to make their vaccine non-exclusive—a potential boon for India, which has dozens of vaccine plants. But then the plan changed: [3]](https://pbs.twimg.com/media/E0rpqevXEAU7XDh.png "It was born out of how the global pharma industry is stacked in favour of big corporations. The Oxford vaccine& #39;s inventors, at first, wanted to make their vaccine non-exclusive—a potential boon for India, which has dozens of vaccine plants. But then the plan changed: [3]")
The Oxford vaccine& #39;s inventors, at first, wanted to make their vaccine non-exclusive—a potential boon for India, which has dozens of vaccine plants. But then the plan changed: [3]
It was born out of what one former Indian govt. official described to me as "ignorance and arrogance." Other countries were advance-ordering vaccines even in mid-2020. India didn& #39;t order until Jan 2021. [4]
![It was born out of what one former Indian govt. official described to me as "ignorance and arrogance." Other countries were advance-ordering vaccines even in mid-2020. India didn& #39;t order until Jan 2021. [4]](https://pbs.twimg.com/media/E0rqVxAX0AEd511.png "It was born out of what one former Indian govt. official described to me as \"ignorance and arrogance.\" Other countries were advance-ordering vaccines even in mid-2020. India didn& #39;t order until Jan 2021. [4]")
Here& #39;s the story, a thorough reckoning of a squandered year. [end] https://qz.com/2004650/?utm_term=mucp">https://qz.com/2004650/...
